Endogenous adenosine prevents post-tetanic release facilitation mediated by α3β2 nicotinic autoreceptors

European Journal of Pharmacology

Volumn 464, Issue 2-3, 2003, Pages 115-125

  Timóteo, M Alexandrina ^a   Faria, Miguel ^a   Correia de Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Acetylcholine release; Adenosine A2A receptor; Adenosine endogenous; Neuromuscular junction; Nicotinic 3 2 receptor; Post tetanic facilitation

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; ALPHA BUNGAROTOXIN; AUTORECEPTOR; DIHYDRO BETA ERYTHROIDINE; NICOTINIC RECEPTOR; TUBOCURARINE CHLORIDE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FACILITATION; FEMALE; MALE; MOTONEURON; MUSCLE CONTRACTION; MUSCLE TWITCH; NERVE ENDING; NERVE STIMULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0037454127     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01374-8     Document Type: Article

References (45)

1. Alexander S.P.H., Peters J.A. Receptor and ion channel nomenclature supplement. Trends Pharmacol. Sci. Suppl. 2000;7-12.
2. Bowman W.C. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth. Analg. 59:1980;935-943.
3. Bowman W.C., Marshall I.G., Gibb A.J., Harborne A.J. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol. Sci. 9:1988;16-20.
4. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271:1996;7522-7528.
5. Chavez-Noriega L.E., Crona J.H., Washburn M.S., Urrutia A., Elliott K.J., Johnson E.C. Pharmacological characterization of recombinant human neuronal acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280:1997;346-356.
6. Colquhoun D., Mathie A., Mulrine N.K., Ogden D.C. Studies on single acetylcholine-receptor channels in muscle endplate and sympathetic neurons. Sellin L.C., Libelius R., Thesleff S. Neuromuscular Junction. 1989;217-234 Elsevier, Amsterdam, NY.
7. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur. J. Pharmacol. 271:1994;349-355.
8. 3H]acetylcholine release from the rat motor nerve terminals. Neuroscience. 73:1996;85-92.
9. Correia-de-Sá P., Sebastião A.M., Ribeiro J.A. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat. Br. J. Pharmacol. 103:1991;1614-1620.
10. 2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J. Neurophysiol. 76:1996;3910-3919.
11. 2A adenosine receptor facilitation of neuromuscular transmission: influence of stimulus paradigm on calcium mobilization. J. Neurochem. 74:2000;2462-2469.
12. Cunha R.A., Sebastião A.M. Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibers upon electrical stimulation of the innervated skeletal muscle of the frog. Pflügers Arch. Eur. J. Physiol. 424:1993;503-510.
13. Cunha R.A., Correia-de-Sá P., Sebastião A.M., Ribeiro J.A. Preferential activation of excitatory adenosine receptors at the rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119:1996;253-260.
14. Dwoskin L.P., Crooks P.A. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J. Pharmacol. Exp. Ther. 298:2001;395-402.
15. Gibb A.J., Marshall I.G. Nicotinic antagonists produce differing amounts of tetanic fade in the isolated diaphragm of the rat. Br. J. Pharmacol. 89:1986;619-624.
16. Hong S.J., Chang C.C. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitisation of the postsynaptic receptor. Br. J. Pharmacol. 102:1991;817-822.
17. Jacobson K.A., van Galen P.J.M., Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35:1992;407-422.
18. James S., Richardson P.J. Production of adenosine from extracellular ATP at striatal cholinergic synapses. J. Neurochem. 60:1993;219-227.
19. Lebowitz P.W., Ramsey F.M., Savarese J.J., Ali H.H., deBros F.M. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesth. Analg. 60:1981;12-17.
20. Léna C., Changeux J.-P. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16:1993;181-186.
21. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;204-210.
22. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J.K., Berg D.K., Bertrand D., Chiappinell V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quick M., Taylor P.W., Wonnacott S. International Union of Pharmacology: XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Res. 51:1999;397-401.
23. Malinowski M.N., Cannady S.B., Schmit K.V., Barr P.M., Schrock J.W., Wilson D.F. Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the rat. Neurosci. Lett. 230:1997;81-84.
24. Nishimura M., Fujise N., Ohtani H., Yagasaki O. Effects of hypoxia, 2,4-dinitrophenol and ouabain on twitch potentiation elicited following conditioning pulses in the mouse phrenic nerve-diaphragm preparation. J. Toxicol. Sci. 12:1987;291-300.
25. Nishizaki T., Sumikawa K. Effects of PKC and PKA phosphorylation on desensitization of nicotinic acetylcholine receptors. Brain Res. 812:1998;242-245.
26. Paul M., Kindler C.H., Fokt R.M., Dipp N.C.J., Yost C.S. Isobolographic analysis of non-depolarising muscle relaxant interactions at their receptor site. Eur. J. Pharmacol. 438:2002;35-43.
27. 1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse. Eur. J. Pharmacol. 327:1997;103-108.
28. Ribeiro J.A., Walker J. The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br. J. Pharmacol. 54:1975;213-218.
29. Road J., Osborne S., Cairns A. Phrenic motoneuron firing rates during brief inspiratory resistive loads. J. Appl. Physiol. 79:1995;1540-1545.
30. Schuetze S.M., Role L.W. Developmental regulation of nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 10:1987;403-457.
31. Sebastião A.M., Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 21:2000;341-346.
32. Silinsky E.M. On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J. Physiol. (Lond.). 247:1975;145-162.
33. Silinsky E.M., Redman R.S. Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J. Physiol. (Lond.). 492:1996;815-822.
34. Singh S., Prior C. Prejunctional effects of the nicotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction. J. Physiol. (Lond.). 511.2:1998;451-460.
35. Tsuneki H., Kimura I., Dezaki K., Kimura M., Sala C., Fumagalli G. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci. Lett. 196:1995;13-16.
36. Vailati S., Hanke W., Bejan A., Barabino B., Longhi R., Balestra B., Moretti M., Clementi F., Gotti C. Functional α6-containing nicotinic receptors are present in chick retina. Mol. Pharmacol. 56:1999;11-19.
37. Van der Kloot W., Molgó J. Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol. Rev. 74:1994;899-991.
38. Vernino S., Rogers M., Radcliffe K.A., Dani J.A. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J. Neurosci. 14:1994;5514-5524.
39. Vizi E.S., Somogyi G.T. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation. Br. J. Pharmacol. 97:1989;65-70.
40. Vizi E.S., Somogyi G.T., Nagashima H., Chaudhry I.A., Kobayashi O., Goldiner P.L., Foldes F.F. Tubocurarine and pancuronium inhibit evoked of acetylcholine from the mouse hemidiaphragm preparation. Br. J. Anaesth. 59:1987;226-231.
41. Voitenko S.V., Bobryshev A.Y., Skok V.I. Intracellular regulation of neuronal nicotinic cholinoceptors. Neurosci. Behav. Physiol. 30:2000;19-25.
42. Waud B.E., Waud D.R. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Anesthesiology. 35:1971;456-464.
43. Wessler I. Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol. Sci. 10:1989;110-114.
44. 3H]-acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn-Schmiedeberg's Arch. Pharmacol. 334:1986;357-364.
45. Wonnacott S. Presynaptic nicotinic receptors. Trends Neurosci. 20:1997;92-98.